AGE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CHRONIC ENALAPRIL TREATMENT

被引：46

作者：

LEES, KR

REID, JL

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 06期

关键词：

D O I：

10.1038/clpt.1987.81

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：597 / 602

页数：6

共 14 条

[1] AGE AND THE PHARMACODYNAMICS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS ENALAPRIL AND ENALAPRILAT [J].

AJAYI, AA ;

HOCKINGS, N ;

REID, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (04) :349-357

[2] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[3]

CHIKNAS SG, 1979, CLIN CHEM, V25, P1259

[4] SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].

CUSHMAN, DW ;

CHEUNG, HS .

BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+

[5]

HICHENS M, 1981, Ligand Quarterly, V4, P43

[6] AGE AND THE PHARMACOKINETICS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS ENALAPRIL AND ENALAPRILAT [J].

HOCKINGS, N ;

AJAYI, AA ;

REID, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (04) :341-348

[7] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS [J].

HODSMAN, GP ;

BROWN, JJ ;

DAVIES, DL ;

FRASER, R ;

LEVER, AF ;

MORTON, JJ ;

MURRAY, GD ;

ROBERTSON, JIS .

BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6356) :1697-1699

[8]

JELLIFFE R W, 1972, Mathematical Biosciences, V14, P17, DOI 10.1016/0025-5564(72)90003-X

[9]

KELMAN AW, 1983, BRIT J CLIN PHARMACO, V15, P506, DOI 10.1111/j.1365-2125.1983.tb01542.x

[10]

Kjekshus J K, 1983, J Hypertens Suppl, V1, P143

← 1 2 →